Form 4: Agilent Technologies Executive Bret DiMarco Acquires Shares and Options

Sentiment:

SEC Form 4 Filing


Senior Vice President Bret DiMarco of Agilent Technologies acquired 3,814 shares of common stock and 11,011 employee stock options on November 27, 2024.

Summary

  • Bret DiMarco, a Senior Vice President at Agilent Technologies, executed transactions involving the company's stock on November 27, 2024.
  • He acquired 3,814 shares of common stock at a price of $138.14 per share.
  • Additionally, he was granted 11,011 employee stock options, also at an exercise price of $138.14.
  • The stock options vest in four equal annual installments starting November 27, 2025, and expire on November 27, 2034.
  • The restricted stock units vest in four equal annual installments beginning on November 27, 2024 and are subject to a 1-year post-vest holding period.
  • Following these transactions, Mr. DiMarco directly owns 5,432 shares of Agilent Technologies common stock.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices and insider transactions, which are generally viewed neutrally to slightly positive by the market. The acquisition of shares by an executive can be seen as a sign of confidence.

Positives

  • The acquisition of shares and options by a senior executive could be seen as a positive sign of confidence in the company's future performance.
  • The vesting schedule of the options and restricted stock units encourages long-term commitment from the executive.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when executives make transactions in their company's stock. It reflects standard executive compensation practices.

Comparison to Industry Standards

  • The vesting schedule of the options and restricted stock units is typical for executive compensation packages in the technology industry.
  • The use of stock options and restricted stock units is a common practice among publicly traded companies to align executive interests with shareholder value.
  • Companies like Thermo Fisher Scientific and Danaher also use similar compensation structures for their executives.

Stakeholder Impact

  • The transactions may have a minor positive impact on shareholder sentiment, as they indicate executive confidence in the company's future.

Key Dates

DateDescription
11/27/2024Date of stock and option acquisition.
11/27/2025First vesting date for the employee stock options.
11/27/2034Expiration date for the employee stock options.
12/02/2024Date the form was signed.

Keywords

Agilent Technologies, stock options, stock acquisition, executive compensation, insider trading, Form 4, Bret DiMarco

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.